SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
11-Mar-24 8:31 PM View: | Intra-Cellular Therapies, I... (ITCI) | 11-Mar-24 | Planned Option Sale | 895 | $65.59 | $58,706.00 | (4%) 23.52K to 22.62K | |
11-Mar-24 8:31 PM View: | Intra-Cellular Therapies, I... (ITCI) | 11-Mar-24 | Sale (Planned) | 2,817 | $65.59 | $184,776.00 | (12%) 22.62K to 19.8K | |
11-Mar-24 8:31 PM View: | Intra-Cellular Therapies, I... (ITCI) | 10-Mar-24 | Option Exercise | 7,345 | -- | -- | 45% 16.17K to 23.52K | |
11-Mar-24 8:31 PM View: | Intra-Cellular Therapies, I... (ITCI) | 07-Mar-24 | Planned Private Option Sale | 6,450 | $66.56 | $429,308.00 | (29%) 22.62K to 16.17K | |
08-Mar-24 5:58 PM View: | Intra-Cellular Therapies, I... (ITCI) | 06-Mar-24 | Option Exercise | 13,132 | -- | -- | 138% 9.49K to 22.62K | |
27-Feb-24 7:58 PM View: | Intra-Cellular Therapies, I... (ITCI) | 26-Feb-24 | Planned Option Sale | 4,112 | $70.17 | $288,534.00 | (30%) 13.6K to 9.49K | |
27-Feb-24 7:58 PM View: | Intra-Cellular Therapies, I... (ITCI) | 23-Feb-24 | Option Exercise | 7,907 | -- | -- | 139% 5.69K to 13.6K | |
05-Feb-24 6:02 PM View: | Intra-Cellular Therapies, I... (ITCI) | 02-Feb-24 | Sale (Planned) | 6,167 | $67.19 | $414,355.00 | (52%) 11.86K to 5.69K | |
05-Feb-24 6:02 PM View: | Intra-Cellular Therapies, I... (ITCI) | 01-Feb-24 | Grant | 11,860 | -- | -- | 100% 0 to 11.86K | |
04-Jan-24 7:54 PM View: | Intra-Cellular Therapies, I... (ITCI) | 02-Jan-24 | Option Exercise | 62,282 | $19.87 | $1,237,540.00 | 100% 0 to 62.28K | |
04-Jan-24 7:54 PM View: | Intra-Cellular Therapies, I... (ITCI) | 02-Jan-24 | Planned Option Sale | 62,282 | $70.60 | $4,397,110.00 | (100%) 62.28K to 0 | |
15-Dec-23 5:01 PM View: | Intra-Cellular Therapies, I... (ITCI) | 13-Dec-23 | Private Sale (Planned) | 21,262 | $65.00 | $1,382,030.00 | (100%) 21.26K to 0 | |
20-Jul-23 5:47 PM View: | Intra-Cellular Therapies, I... (ITCI) | 17-Jul-23 | Private Sale (Planned) | 1,842 | $65.00 | $119,730.00 | (8%) 23.1K to 21.26K | |
13-Mar-23 7:36 PM View: | Intra-Cellular Therapies, I... (ITCI) | 13-Mar-23 | Planned Option Sale | 7,344 | $45.04 | $330,794.00 | (24%) 30.45K to 23.1K | |
13-Mar-23 7:36 PM View: | Intra-Cellular Therapies, I... (ITCI) | 10-Mar-23 | Option Exercise | 7,344 | -- | -- | 32% 23.1K to 30.45K | |
27-Feb-23 8:02 PM View: | Intra-Cellular Therapies, I... (ITCI) | 24-Feb-23 | Planned Option Sale | 7,906 | $47.14 | $372,689.00 | (25%) 31.01K to 23.1K | |
27-Feb-23 8:02 PM View: | Intra-Cellular Therapies, I... (ITCI) | 23-Feb-23 | Option Exercise | 7,906 | -- | -- | 34% 23.1K to 31.01K | |
22-Feb-23 8:04 PM View: | Intra-Cellular Therapies, I... (ITCI) | 21-Feb-23 | Planned Option Sale | 8,354 | $46.84 | $391,304.00 | (27%) 31.46K to 23.1K | |
22-Feb-23 8:04 PM View: | Intra-Cellular Therapies, I... (ITCI) | 18-Feb-23 | Option Exercise | 8,354 | -- | -- | 36% 23.1K to 31.46K | |
04-Mar-22 6:05 PM View: | Intra-Cellular Therapies, I... (ITCI) | 04-Mar-22 | Sale (Planned) | 3,860 | $55.52 | $214,307.00 | (14%) 26.96K to 23.1K | |
04-Mar-22 6:05 PM View: | Intra-Cellular Therapies, I... (ITCI) | 02-Mar-22 | Private Sale (Planned) | 4,177 | $56.98 | $238,005.00 | (13%) 31.14K to 26.96K | |
25-Feb-22 7:09 PM View: | Intra-Cellular Therapies, I... (ITCI) | 24-Feb-22 | Planned Option Sale | 4,046 | $52.27 | $211,468.00 | (11%) 35.19K to 31.14K | |
25-Feb-22 7:09 PM View: | Intra-Cellular Therapies, I... (ITCI) | 23-Feb-22 | Option Exercise | 7,906 | -- | -- | 29% 27.28K to 35.19K | |
23-Feb-22 7:08 PM View: | Intra-Cellular Therapies, I... (ITCI) | 22-Feb-22 | Planned Option Sale | 4,177 | $55.29 | $230,958.00 | (13%) 31.46K to 27.28K | |
23-Feb-22 7:08 PM View: | Intra-Cellular Therapies, I... (ITCI) | 18-Feb-22 | Option Exercise | 8,354 | -- | -- | 36% 23.1K to 31.46K | |
20-Jan-22 4:07 PM View: | Intra-Cellular Therapies, I... (ITCI) | 18-Jan-22 | Market Sale (Planned) | 6,223 | $42.03 | $261,553.00 | (21%) 29.33K to 23.1K | 2% |
11-Jan-22 8:08 PM View: | Intra-Cellular Therapies, I... (ITCI) | 10-Jan-22 | Market Option Sale (Planned) | 6,870 | $40.76 | $280,020.00 | (19%) 36.2K to 29.33K | |
11-Jan-22 8:08 PM View: | Intra-Cellular Therapies, I... (ITCI) | 08-Jan-22 | Option Exercise | 13,093 | -- | -- | 57% 23.1K to 36.2K | |
22-Feb-21 8:09 PM View: | Intra-Cellular Therapies, I... (ITCI) | 19-Feb-21 | Market Option Sale (Planned) | 2,734 | $39.25 | $107,310.00 | (11%) 25.84K to 23.1K | |
22-Feb-21 8:09 PM View: | Intra-Cellular Therapies, I... (ITCI) | 18-Feb-21 | Option Exercise | 8,354 | -- | -- | 48% 17.48K to 25.84K | |
12-Jan-21 7:07 PM View: | Intra-Cellular Therapies, I... (ITCI) | 11-Jan-21 | Market Option Sale (Planned) | 4,367 | $32.12 | $140,259.00 | (20%) 21.85K to 17.48K | |
12-Jan-21 7:07 PM View: | Intra-Cellular Therapies, I... (ITCI) | 08-Jan-21 | Option Exercise | 13,092 | -- | -- | 149% 8.76K to 21.85K |